Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase

被引:39
作者
Blaquiere, Nicole [1 ]
Castanedo, Georgette M. [1 ]
Burch, Jason D. [1 ]
Berezhkovskiy, Leonid M. [1 ]
Brightbill, Hans [1 ]
Brown, Suzanne [1 ]
Chan, Connie [1 ]
Chiang, Po-Chang [1 ]
Crawford, James J. [1 ]
Dong, Teresa [1 ]
Fan, Peter [1 ]
Feng, Jianwen [1 ]
Ghilardi, Nico [1 ]
Godemann, Robert [3 ]
Gogol, Emily [1 ]
Grabbe, Alice [3 ]
Hole, Alison J. [3 ]
Hu, Baihua [2 ]
Hymowitz, Sarah G. [1 ]
Ismaili, Moulay Hicham Alaoui [1 ]
Le, Hoa [1 ]
Lee, Patrick [1 ]
Lee, Wyne [1 ]
Lin, Xingyu [2 ]
Liu, Ning [1 ]
McEwan, Paul A. [3 ]
McKenzie, Brent [1 ]
Silvestre, Hernani L. [3 ]
Suto, Eric [1 ]
Sujatha-Bhaskar, Swathi [1 ]
Wu, Guosheng [2 ]
Wu, Lawren C. [1 ]
Zhang, Yamin [2 ]
Zhong, Zoe [1 ]
Staben, Steven T. [1 ]
机构
[1] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA
[2] Pharmaron Beijing Co Ltd, 6 Taihe Rd, Beijing 100176, Peoples R China
[3] Evotec AG, Manfred Eigen Campus, D-22419 Hamburg, Germany
关键词
LYMPHOCYTE STIMULATOR; SIGNALING PATHWAY; PROTEIN-KINASES; ACTIVATION; NIK; IDENTIFICATION; CONFORMATION; DISEASE; TRAF2; ALPHA;
D O I
10.1021/acs.jmedchem.8b00678
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
NF-kappa B -inducing kinase (NIK) is a protein kinase central to the noncanonical NF-kappa B pathway downstream from multiple TNF receptor family members, including BAFF, which has been associated with B cell survival and maturation, dendritic cell activation, secondary lymphoid organ development, and bone metabolism. We report herein the discovery of lead chemical series of NIK inhibitors that were identified through a scaffold-hopping strategy using structure-based design. Electronic and steric properties of lead compounds were modified to address glutathione conjugation and amide hydrolysis. These highly potent compounds exhibited selective inhibition of LT beta R-dependent p52. translocation and transcription of NF-kappa B2 related genes. Compound 4f is shown to have a favorable pharmacokinetic profile across species and to inhibit BAFF-induced B cell survival in vitro and reduce splenic marginal zone B cells in vivo.
引用
收藏
页码:6801 / 6813
页数:13
相关论文
共 41 条
[1]  
Angiolini M, 2011, FUTURE MED CHEM, V3, P309, DOI [10.4155/FMC.10.294, 10.4155/fmc.10.294]
[2]  
[Anonymous], 2013, METHODS PRINCIPLES M
[3]  
Blaquiere N., 2015, Patent No. 2015025025
[4]  
Blaquiere N., 2016, Patent No. 2016135163
[5]  
Blaquiere N., 2015, Alkynyl alcohols and methods of use. F. Hoffmann-La Roche Ag, Genentech, Inc, Patent No. [WO 2015025026 A1, 2015025026]
[6]   NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus [J].
Brightbill, Hans D. ;
Suto, Eric ;
Blaquiere, Nicole ;
Ramamoorthi, Nandhini ;
Sujatha-Bhaskar, Swathi ;
Gogol, Emily B. ;
Castanedo, Georgette M. ;
Jackson, Benjamin T. ;
Kwon, Youngsu C. ;
Haller, Susan ;
Lesch, Justin ;
Bents, Karin ;
Everett, Christine ;
Kohli, Pawan Bir ;
Linge, Sandra ;
Christian, Laura ;
Barrett, Kathy ;
Jaochico, Allan ;
Berezhkovskiy, Leonid M. ;
Fan, Peter W. ;
Modrusan, Zora ;
Veliz, Kelli ;
Townsend, Michael J. ;
DeVoss, Jason ;
Johnson, Adam R. ;
Godemann, Robert ;
Lee, Wyne P. ;
Austin, Cary D. ;
McKenzie, Brent S. ;
Hackney, Jason A. ;
Crawford, James J. ;
Staben, Steven T. ;
Ismaili, Moulay H. Alaoui ;
Wu, Lawren C. ;
Ghilardi, Nico .
NATURE COMMUNICATIONS, 2018, 9
[7]   Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K) [J].
Castanedo, Georgette M. ;
Blaquiere, Nicole ;
Beresini, Maureen ;
Bravo, Brandon ;
Brightbill, Hans ;
Chen, Jacob ;
Cui, Hai-Feng ;
Eigenbrot, Charles ;
Everett, Christine ;
Feng, Jianwen ;
Godemann, Robert ;
Gogol, Emily ;
Hymowitz, Sarah ;
Johnson, Adam ;
Kayagald, Nobuhiko ;
Kohli, Pawan Bir ;
Knueppel, Kathleen ;
Kraemer, Joachim ;
Krueger, Susan ;
Loke, Pui ;
McEwan, Paul ;
Montalbetti, Christian ;
Roberts, David A. ;
Smith, Myron ;
Steinbacher, Stefan ;
Sujatha-Bhaskar, Swathi ;
Takahashi, Ryan ;
Wane, Xiaolu ;
Wu, Lawren C. ;
Zhang, Yamin ;
Staben, Steven T. .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (02) :627-640
[8]  
Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO
[9]  
2-S
[10]  
Chen G., 2009, World Patent, Patent No. [WO2009158011, 2009158011, WO2009/158011, 02009158011]